Currently out of the existing stock ratings of Kallum Titchmarsh, 2 are a SELL (4.65%), 27 are a HOLD (62.79%), 14 are a BUY (32.56%).

Kallum Titchmarsh

Work Performance Price Targets & Ratings Chart

Analyst Kallum Titchmarsh, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 58.45% that have a potential upside of 12.35% achieved within 34 days.

Kallum Titchmarsh’s has documented 83 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on A, Agilent Technologies at 12-Aug-2026.

Wall Street Analyst Kallum Titchmarsh

Analyst best performing recommendations are on EMBC (EMBECTA CORP).
The best stock recommendation documented was for ATEC (ALPHATEC HOLDINGS) at 12/2/2024. The price target of $10 was fulfilled within 1 day with a profit of $0.21 (2.06%) receiving and performance score of 20.57.

Average potential price target upside

of $58.49 (36.91%) on INSP (INSPIRE MEDICAL SYSTEMS).
of $26.8 (13.74%) on PEN (PENUMBRA).
of $17.55 (5.1%) on WAT (WATERS).

A Agilent Technologies ATEC Alphatec Holdings EMBC Embecta Corp GMED Globus Medical INSP Inspire Medical Systems MTD Mettler-Toledo International PEN Penumbra SGHT Sight Sciences SIBN Si-Bone WAT Waters

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Kallum Titchmarsh (MORGAN STANLEY)